Expanding Clinical Expertise Alimentiv’s leading position in specialty GI clinical research, with a focus on IBD, positions it as an ideal partner for pharmaceutical companies developing new treatments in gastroenterology and inflammatory bowel diseases, offering tailored clinical trial solutions and advanced medical imaging services.

Innovative AI Solutions The recent launch of AI scoring tools for ulcerative colitis presents an opportunity to collaborate with Alimentiv on integrating AI-driven technology into clinical trials, enhancing data accuracy and efficiency for biotech and pharma partners seeking innovative diagnostic and assessment tools.

Global Network Reach With a presence in over 60 countries and a network of more than 5,000 sites, Alimentiv can assist clients in expanding their clinical trial footprint internationally, reducing time-to-market through accelerated study activation and diverse patient enrollment strategies.

Research and Development Focus Alimentiv’s ongoing participation in leading conferences and robust publication output indicate a strong commitment to advancing GI research, making it a valuable collaborator for companies seeking cutting-edge clinical data and innovative research partnerships.

Investment in Data Analytics The launch of Alimentiv Statistics and the development of a dedicated Statistics Centre of Excellence highlight opportunities to provide advanced statistical and analytical services to optimize clinical trial data management, analysis, and regulatory submission efficiency.